136 related articles for article (PubMed ID: 36066189)
1. Risk factors for hospitalization or mortality for COVID-19 in patients with rheumatic diseases: Results of a nationwide JCR COVID-19 registry in Japan.
Oku K; Kimoto Y; Horiuchi T; Yamamoto M; Kondo Y; Okamoto M; Atsumi T; Takeuchi T
Mod Rheumatol; 2023 Jul; 33(4):768-776. PubMed ID: 36066189
[TBL] [Abstract][Full Text] [Related]
2. Sociodemographic and clinical factors associated with poor COVID-19 outcomes in patients with rheumatic diseases: data from the SAR-COVID Registry.
Isnardi CA; Roberts K; Saurit V; Petkovic I; Báez RM; Quintana R; Tissera Y; Ornella S; D Angelo Exeni ME; Pisoni CN; Castro Coello VV; Berbotto G; Haye Salinas MJ; Velozo E; Reyes Torres ÁA; Tanten R; Zelaya MD; Gobbi C; Alonso CG; de Los Ángeles Severina M; Vivero F; Paula A; Cogo AK; Alle G; Pera M; Nieto RE; Cosatti M; Asnal C; Pereira D; Albiero JA; Savio VG; Maldonado FN; Gamba MJ; Germán NF; Baños A; Gallino Yanzi J; Gálvez Elkin MS; Morbiducci JS; Martire MV; Maldonado Ficco H; Schmid MM; Villafañe Torres JA; de Los Ángeles Correa M; Medina MA; Cusa MA; Scafati J; Agüero SE; Lloves Schenone NM; Soriano ER; Graf C; Pons-Estel BA; Gomez G; Landi M; De la Vega MC; Pons-Estel GJ;
Clin Rheumatol; 2023 Feb; 42(2):563-578. PubMed ID: 36201124
[TBL] [Abstract][Full Text] [Related]
3. Clinical characteristics of COVID-19 patients with underlying rheumatic diseases in Japan: data from a multicenter observational study using the COVID-19 Global Rheumatology Alliance physician-reported registry.
Kihara M; Sugihara T; Asano J; Sato M; Kaneko H; Muraoka S; Ohshima S; Nanki T
Clin Rheumatol; 2022 Dec; 41(12):3661-3673. PubMed ID: 35974224
[TBL] [Abstract][Full Text] [Related]
4. Determinants of COVID-19 disease severity in patients with underlying rheumatic disease.
Santos CS; Morales CM; Álvarez ED; Castro CÁ; Robles AL; Sandoval TP
Clin Rheumatol; 2020 Sep; 39(9):2789-2796. PubMed ID: 32720259
[TBL] [Abstract][Full Text] [Related]
5. Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry.
Gianfrancesco M; Hyrich KL; Al-Adely S; Carmona L; Danila MI; Gossec L; Izadi Z; Jacobsohn L; Katz P; Lawson-Tovey S; Mateus EF; Rush S; Schmajuk G; Simard J; Strangfeld A; Trupin L; Wysham KD; Bhana S; Costello W; Grainger R; Hausmann JS; Liew JW; Sirotich E; Sufka P; Wallace ZS; Yazdany J; Machado PM; Robinson PC;
Ann Rheum Dis; 2020 Jul; 79(7):859-866. PubMed ID: 32471903
[TBL] [Abstract][Full Text] [Related]
6. Clinical outcomes of hospitalised patients with COVID-19 and chronic inflammatory and autoimmune rheumatic diseases: a multicentric matched cohort study.
Pablos JL; Galindo M; Carmona L; Lledó A; Retuerto M; Blanco R; Gonzalez-Gay MA; Martinez-Lopez D; Castrejón I; Alvaro-Gracia JM; Fernández Fernández D; Mera-Varela A; Manrique-Arija S; Mena Vázquez N; Fernandez-Nebro A; ;
Ann Rheum Dis; 2020 Dec; 79(12):1544-1549. PubMed ID: 32796045
[TBL] [Abstract][Full Text] [Related]
7. Association of Race and Ethnicity With COVID-19 Outcomes in Rheumatic Disease: Data From the COVID-19 Global Rheumatology Alliance Physician Registry.
Gianfrancesco MA; Leykina LA; Izadi Z; Taylor T; Sparks JA; Harrison C; Trupin L; Rush S; Schmajuk G; Katz P; Jacobsohn L; Hsu TY; D'Silva KM; Serling-Boyd N; Wallwork R; Todd DJ; Bhana S; Costello W; Grainger R; Hausmann JS; Liew JW; Sirotich E; Sufka P; Wallace ZS; Machado PM; Robinson PC; Yazdany J;
Arthritis Rheumatol; 2021 Mar; 73(3):374-380. PubMed ID: 33146001
[TBL] [Abstract][Full Text] [Related]
8. Biological agents for rheumatic diseases in the outbreak of COVID-19: friend or foe?
Santos CS; Férnandez XC; Moriano Morales C; Álvarez ED; Álvarez Castro C; López Robles A; Pérez Sandoval T
RMD Open; 2021 Jan; 7(1):. PubMed ID: 33455920
[TBL] [Abstract][Full Text] [Related]
9. Temporal trends in COVID-19 outcomes in people with rheumatic diseases in Ireland: data from the COVID-19 Global Rheumatology Alliance registry.
Conway R; Nikiphorou E; Demetriou CA; Low C; Leamy K; Ryan JG; Kavanagh R; Fraser AD; Carey JJ; O'Connell P; Flood RM; Mullan RH; Kane DJ; Ambrose N; Stafford F; Robinson PC; Liew JW; Grainger R; McCarthy GM;
Rheumatology (Oxford); 2022 Jun; 61(SI2):SI151-SI156. PubMed ID: 35258593
[TBL] [Abstract][Full Text] [Related]
10. Severity of COVID-19 and survival in patients with rheumatic and inflammatory diseases: data from the French RMD COVID-19 cohort of 694 patients.
FAI2R /SFR/SNFMI/SOFREMIP/CRI/IMIDIATE consortium and contributors
Ann Rheum Dis; 2021 Apr; 80(4):527-538. PubMed ID: 33268442
[TBL] [Abstract][Full Text] [Related]
11. Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry.
Strangfeld A; Schäfer M; Gianfrancesco MA; Lawson-Tovey S; Liew JW; Ljung L; Mateus EF; Richez C; Santos MJ; Schmajuk G; Scirè CA; Sirotich E; Sparks JA; Sufka P; Thomas T; Trupin L; Wallace ZS; Al-Adely S; Bachiller-Corral J; Bhana S; Cacoub P; Carmona L; Costello R; Costello W; Gossec L; Grainger R; Hachulla E; Hasseli R; Hausmann JS; Hyrich KL; Izadi Z; Jacobsohn L; Katz P; Kearsley-Fleet L; Robinson PC; Yazdany J; Machado PM;
Ann Rheum Dis; 2021 Jul; 80(7):930-942. PubMed ID: 33504483
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for hospital admissions related to COVID-19 in patients with autoimmune inflammatory rheumatic diseases.
Freites Nuñez DD; Leon L; Mucientes A; Rodriguez-Rodriguez L; Font Urgelles J; Madrid García A; Colomer JI; Jover JA; Fernandez-Gutierrez B; Abasolo L
Ann Rheum Dis; 2020 Nov; 79(11):1393-1399. PubMed ID: 32769150
[TBL] [Abstract][Full Text] [Related]
13. COVID-19 infection among autoimmune rheumatic disease patients: Data from an observational study and literature review.
Bakasis AD; Mavragani CP; Boki KA; Tzioufas AG; Vlachoyiannopoulos PG; Stergiou IE; Skopouli FN; Moutsopoulos HM
J Autoimmun; 2021 Sep; 123():102687. PubMed ID: 34311142
[TBL] [Abstract][Full Text] [Related]
14. Clinical characteristics and COVID-19 outcomes in a regional cohort of pediatric patients with rheumatic diseases.
Clemente D; Udaondo C; de Inocencio J; Nieto JC; Del Río PG; Fernández AG; Palomo JA; Bachiller-Corral J; Lopez Robledillo JC; Millán Longo C; Leon L; Abasolo L; Boteanu A
Pediatr Rheumatol Online J; 2021 Nov; 19(1):162. PubMed ID: 34838054
[TBL] [Abstract][Full Text] [Related]
15. COVID-19 outcomes among rheumatic disease patients in Kuwait: Data from the COVID-19 Global Rheumatology Alliance (C19-GRA) physician registry.
Abutiban F; Saleh K; Hayat S; Tarakmah H; Al-Herz A; Ghanem A
Int J Rheum Dis; 2022 Jul; 25(7):743-754. PubMed ID: 35543332
[TBL] [Abstract][Full Text] [Related]
16. Older age, comorbidity, glucocorticoid use and disease activity are risk factors for COVID-19 hospitalisation in patients with inflammatory rheumatic and musculoskeletal diseases.
Hasseli R; Mueller-Ladner U; Hoyer BF; Krause A; Lorenz HM; Pfeil A; Richter J; Schäfer M; Schmeiser T; Strangfeld A; Schulze-Koops H; Voll RE; Specker C; Regierer AC
RMD Open; 2021 Jan; 7(1):. PubMed ID: 33479021
[TBL] [Abstract][Full Text] [Related]
17. Predictors of hospitalization for COVID-19 in patients with autoimmune rheumatic diseases: results from a community cohort follow-up.
Gamboa-Cárdenas RV; Barzola-Cerrón S; Toledo-Neira D; Reátegui-Sokolova C; Pimentel-Quiroz V; Zevallos-Miranda F; Alarcón GS; Ugarte-Gil M
Clin Rheumatol; 2021 Nov; 40(11):4725-4734. PubMed ID: 34189675
[TBL] [Abstract][Full Text] [Related]
18. Risk of coronavirus disease 2019 hospitalization and mortality in rheumatic patients treated with hydroxychloroquine or other conventional disease-modifying anti-rheumatic drugs in Italy.
Spila Alegiani S; Crisafulli S; Giorgi Rossi P; Mancuso P; Salvarani C; Atzeni F; Gini R; Kirchmayer U; Belleudi V; Kurotschka PK; Leoni O; Ludergnani M; Ferroni E; Baracco S; Massari M; Trifirò G;
Rheumatology (Oxford); 2021 Oct; 60(SI):SI25-SI36. PubMed ID: 33856453
[TBL] [Abstract][Full Text] [Related]
19. Clinical course and outcomes of COVID-19 in rheumatic disease patients: a case cohort study with a diverse population.
Arleo T; Tong D; Shabto J; O'Keefe G; Khosroshahi A
Clin Rheumatol; 2021 Jul; 40(7):2633-2642. PubMed ID: 33420870
[TBL] [Abstract][Full Text] [Related]
20. Severe COVID-19 in patients with immune-mediated rheumatic diseases: A stratified analysis from the SORCOM multicentre registry.
Boteanu A; Leon L; Pérez Esteban S; Rabadán Rubio E; Pavía Pascual M; Bonilla G; Bonilla González-Laganá C; García Fernandez A; Recuero Diaz S; Ruiz Gutierrez L; Sanmartín Martínez JJ; de la Torre-Rubio N; Nuño L; Sánchez Pernaute O; Del Bosque I; Lojo Oliveira L; Rodríguez Heredia JM; Clemente D; Abasolo L; Bachiller-Corral J
Mod Rheumatol; 2023 Dec; 34(1):97-105. PubMed ID: 36516217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
